Adverse events associated with EGD and EGD-related techniques

TY - JOUR

T1 - Adverse events associated with EGD and EGD-related techniques

AU - ASGE Standards of Practice Committee

AU - Coelho-Prabhu, Nayantara

AU - Forbes, Nauzer

AU - Thosani, Nirav C.

AU - Storm, Andrew C.

AU - Pawa, Swati

AU - Kohli, Divyanshoo R.

AU - Fujii-Lau, Larissa L.

AU - Elhanafi, Sherif

AU - Calderwood, Audrey H.

AU - Buxbaum, James L.

AU - Kwon, Richard S.

AU - Amateau, Stuart K.

AU - Al-Haddad, Mohammad A.

AU - Qumseya, Bashar J.

N1 - Funding Information: The following authors disclosed financial relationships: N. Coelho-Prabhu is a consultant for Boston Scientific Corporation. N. Forbes is a consultant for Boston Scientific Corporation, Pentax of America, Inc, and Pendopharm Inc; is on the speaker bureau for Pentax of America, Inc and Boston Scientific Corporation; and has received research support from Pentax of America, Inc. N. Thosani is a consultant for and has received travel compensation and food and beverage from Boston Scientific Corporation; is a consultant and has received food and beverage from Covidien LP and Pentax of America, Inc; has been a speaker for AbbVie Inc; and has received food and beverage from Erbe USA, Inc and Ambu Inc. A. Storm is a consultant for and has received travel compensation from Apollo Endosurgery US Inc; is a consultant for GI Dynamics, Erbe, and Olympus Corporation of the Americas; is a consultant for and has received a research grant from Endo-TAGSS and Apollo Endosurgery; has received a research grant from Enterasense, Boston Scientific Corporation, and Endogenex; and has received food and beverage from Ambu Inc, Olympus Corporation of the Americas, Micro-tech Endoscopy USA, Inc, and Boston Scientific Corporation. D. Kohli has received a grant from Olympus Corporation of the Americas. L. Fujii-Lau has received food and beverage from Pfizer Inc and AbbVie Inc. S. Elhanafi has received travel compensation and food and beverage from Endogastric Solutions and Boston Scientific Corporation; has received food and beverage from Merit Medical Systems, Inc, Salix Pharmaceuticals, and Intercept Pharmaceuticals. J. Buxbaum is a consultant for and has received grant, travel compensation, and food and beverage compensation from Olympus America Inc; is a consultant for and received food and beverage compensation from Boston Scientific Corporation; is a consultant for Eagle Pharmaceuticals, Inc and Cook Medical LLC; has received grant compensation from Medtronic USA, Inc; and has received consulting fees from Gyrus ACMI, Inc and Wilson Cook Medical Incorporated. R. Kwon has received research support from AbbVie, Inc. S. Amateau is a consultant for and has received travel compensation and food and beverage from Olympus America Inc; is a consultant for and has received travel compensation from Cook Medical LLC; is a consultant for and has received food and beverage from Boston Scientific Corporation; and is a consultant for Endo-Therapeutics, Hemostasis LLC, Heraeus Medical Components, LLC, Merit Medical Systems Inc, Steris Corporation, and Taewoong Medical. M. Al-Haddad has received research support from Cook Endoscopy and Creatics, LLC; is a consultant for and has received teaching support from Boston Scientific Corporation. B. Qumseya has received food and beverage from Olympus America Inc. All other authors disclosed no financial relationships. Funding Information: This document was funded exclusively by the American Society for Gastrointestinal Endoscopy; no outside funding was received to support the development of this document.

PY - 2022/9

Y1 - 2022/9

UR - http://www.scopus.com/inward/record.url?scp=85134843993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85134843993&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2022.04.024

DO - 10.1016/j.gie.2022.04.024

M3 - Article

C2 - 35843754

AN - SCOPUS:85134843993

SN - 0016-5107

VL - 96

SP - 389-401.e1

JO - Gastrointestinal endoscopy

JF - Gastrointestinal endoscopy

IS - 3

ER -